{"id":59676,"date":"2023-09-11T15:26:09","date_gmt":"2023-09-11T19:26:09","guid":{"rendered":"https:\/\/ifintechworld.com\/markets\/is-regeneron-stock-fully-valued-at-820\/"},"modified":"2023-09-11T15:26:12","modified_gmt":"2023-09-11T19:26:12","slug":"is-regeneron-stock-fully-valued-at-820","status":"publish","type":"post","link":"https:\/\/ifintechworld.com\/?p=59676","title":{"rendered":"Is Regeneron Stock Fully Valued At $820?"},"content":{"rendered":"
\n

Regeneron stock<\/strong> (NASDAQ
\n NDAQ
\n <\/fbs-ticker>: REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be attributed to earlier-than-expected regulatory approval for a high-dose version of its eye treatment – Eylea. In the longer term, REGN stock is up a solid 120% from levels seen in late 2019, far better than the S&P 500 index, up nearly 40%.<\/p>\n

Interestingly, REGN stock has had a Sharpe Ratio of 0.5<\/strong> since early 2017, slightly lower than 0.6<\/strong> for the S&P 500 Index over the same period. This compares with the Sharpe of 1.3<\/strong> for the Trefis Reinforced Value portfolio. Sharpe is a measure of return per unit of risk, and high-performance portfolios can provide the best of both worlds.<\/p>\n

This 120% rise for Regeneron stock since late 2019 can primarily be attributed to 1. <\/strong>the company\u2019s P\/S ratio rising 50%<\/strong> to 12.6x revenues vs. 8.4x in 2019, 2.<\/strong> Regeneron\u2019s revenue <\/strong>growth of 44%<\/strong> to $6.9 billion over the last twelve months, compared to $4.8 billion in 2019, and 3.<\/strong> a 1.5%<\/strong> fall in its total shares outstanding to 107 million. This has meant that the company\u2019s revenue per share metric has risen 46% to $65.02 now, compared to $44.60 in 2019. Our dashboard on Why Regeneron Stock Moved<\/strong> has more details.<\/p>\n

<\/fbs-ad><\/p>\n

Regeneron saw its sales rise in recent years, led by its Covid-19 multi-antibody therapy, which garnered $6 billion in 2021 sales. However, with the pandemic now behind us, sales declined in 2022. Another contributor to its top-line growth is Eylea, garnering $6.3 billion in 2022. Eylea is approved for treating wet age-related macular degeneration. It is also used to treat diabetic eye disease and other retina problems. With its recent approval of a high-dose version of Eylea, sales will likely grow faster. However, Eylea could face biosimilar competition as early as next year. The company has another blockbuster drug – Dupixent (co-markets with Sanofi) – a treatment for eczema. The drug garnered $5.3 billion in sales in the first half of this year, reflecting a 35% y-o-y growth. Not only did Regeneron see its sales rise, but it also expanded its operating margin from 28.1% in 2019 to 39.9% in 2022.<\/p>\n

After its recent rise, REGN stock looks like it has little room for growth. It trades at 13x revenues compared to its last five-year average of 9x. Our Regeneron Valuation Ratios Comparison<\/strong> dashboard has more details. Given the uptick in Dupixent sales, a slight upward revision in the sales multiple looks justified. That said, at its current level of $820, the positives appear to be priced in.<\/p>\n

Invest with Trefis <\/strong>Market Beating Portfolios<\/strong><\/p>\n

See all Trefis <\/strong>Price Estimates<\/strong><\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Regeneron stock (NASDAQ NDAQ : REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be attributed to earlier-than-expected regulatory approval for a high-dose version of its eye treatment – Eylea. In the longer term, REGN stock is up a solid 120% from […]<\/p>\n","protected":false},"author":1,"featured_media":59677,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[241],"tags":[83],"class_list":["post-59676","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-featured"],"yoast_head":"\nIs Regeneron Stock Fully Valued At $820? | iFintechWorld<\/title>\n<meta name=\"description\" content=\"Regeneron stock (NASDAQ NDAQ : REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ifintechworld.com\/?p=59676\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Is Regeneron Stock Fully Valued At $820? | iFintechWorld\" \/>\n<meta property=\"og:description\" content=\"Regeneron stock (NASDAQ NDAQ : REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ifintechworld.com\/?p=59676\" \/>\n<meta property=\"og:site_name\" content=\"iFintechWorld\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-11T19:26:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-11T19:26:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/09\/1694460370_0x0.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"798\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ifintechworld.com\/?p=59676#article\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=59676\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\"},\"headline\":\"Is Regeneron Stock Fully Valued At $820?\",\"datePublished\":\"2023-09-11T19:26:09+00:00\",\"dateModified\":\"2023-09-11T19:26:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=59676\"},\"wordCount\":430,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ifintechworld.com\/?p=59676#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ifintechworld.com\/?p=59676\",\"url\":\"https:\/\/ifintechworld.com\/?p=59676\",\"name\":\"Is Regeneron Stock Fully Valued At $820? | iFintechWorld\",\"isPartOf\":{\"@id\":\"https:\/\/ifintechworld.com\/#website\"},\"datePublished\":\"2023-09-11T19:26:09+00:00\",\"dateModified\":\"2023-09-11T19:26:12+00:00\",\"description\":\"Regeneron stock (NASDAQ NDAQ : REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be\",\"breadcrumb\":{\"@id\":\"https:\/\/ifintechworld.com\/?p=59676#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ifintechworld.com\/?p=59676\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ifintechworld.com\/?p=59676#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ifintechworld.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Is Regeneron Stock Fully Valued At $820?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ifintechworld.com\/#website\",\"url\":\"https:\/\/ifintechworld.com\/\",\"name\":\"Repay Down\",\"description\":\"Latest Personal Finance News, Tips and Updates\",\"publisher\":{\"@id\":\"https:\/\/ifintechworld.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ifintechworld.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ifintechworld.com\/#organization\",\"name\":\"Repay Down\",\"url\":\"https:\/\/ifintechworld.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png\",\"width\":558,\"height\":90,\"caption\":\"Repay Down\"},\"image\":{\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"contentUrl\":\"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/ifintechworld.com\"],\"url\":\"https:\/\/ifintechworld.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Is Regeneron Stock Fully Valued At $820? | iFintechWorld","description":"Regeneron stock (NASDAQ NDAQ : REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ifintechworld.com\/?p=59676","og_locale":"en_US","og_type":"article","og_title":"Is Regeneron Stock Fully Valued At $820? | iFintechWorld","og_description":"Regeneron stock (NASDAQ NDAQ : REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be","og_url":"https:\/\/ifintechworld.com\/?p=59676","og_site_name":"iFintechWorld","article_published_time":"2023-09-11T19:26:09+00:00","article_modified_time":"2023-09-11T19:26:12+00:00","og_image":[{"width":1200,"height":798,"url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/09\/1694460370_0x0.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ifintechworld.com\/?p=59676#article","isPartOf":{"@id":"https:\/\/ifintechworld.com\/?p=59676"},"author":{"name":"News Room","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61"},"headline":"Is Regeneron Stock Fully Valued At $820?","datePublished":"2023-09-11T19:26:09+00:00","dateModified":"2023-09-11T19:26:12+00:00","mainEntityOfPage":{"@id":"https:\/\/ifintechworld.com\/?p=59676"},"wordCount":430,"commentCount":0,"publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"keywords":["Featured"],"articleSection":["Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ifintechworld.com\/?p=59676#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ifintechworld.com\/?p=59676","url":"https:\/\/ifintechworld.com\/?p=59676","name":"Is Regeneron Stock Fully Valued At $820? | iFintechWorld","isPartOf":{"@id":"https:\/\/ifintechworld.com\/#website"},"datePublished":"2023-09-11T19:26:09+00:00","dateModified":"2023-09-11T19:26:12+00:00","description":"Regeneron stock (NASDAQ NDAQ : REGN) has seen a 6% rise in a month, compared to a 1% fall for the broader S&P500 index. This outperformance can be","breadcrumb":{"@id":"https:\/\/ifintechworld.com\/?p=59676#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ifintechworld.com\/?p=59676"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ifintechworld.com\/?p=59676#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ifintechworld.com\/"},{"@type":"ListItem","position":2,"name":"Is Regeneron Stock Fully Valued At $820?"}]},{"@type":"WebSite","@id":"https:\/\/ifintechworld.com\/#website","url":"https:\/\/ifintechworld.com\/","name":"Repay Down","description":"Latest Personal Finance News, Tips and Updates","publisher":{"@id":"https:\/\/ifintechworld.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ifintechworld.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ifintechworld.com\/#organization","name":"Repay Down","url":"https:\/\/ifintechworld.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/rep-logo-dark.png","width":558,"height":90,"caption":"Repay Down"},"image":{"@id":"https:\/\/ifintechworld.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/6224724fd4116361255b179dc5c70b61","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ifintechworld.com\/#\/schema\/person\/image\/","url":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","contentUrl":"https:\/\/ifintechworld.com\/wp-content\/uploads\/2023\/04\/avatar_user_1_1682606986-96x96.png","caption":"News Room"},"sameAs":["https:\/\/ifintechworld.com"],"url":"https:\/\/ifintechworld.com\/?author=1"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/59676","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=59676"}],"version-history":[{"count":1,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/59676\/revisions"}],"predecessor-version":[{"id":59678,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/posts\/59676\/revisions\/59678"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=\/wp\/v2\/media\/59677"}],"wp:attachment":[{"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=59676"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=59676"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ifintechworld.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=59676"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}